Coherus Oncology (CHRS) EBIT Margin Growth (3y) (2016 - 2026)
Coherus Oncology (CHRS) EBIT Margin Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBIT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Coherus Oncology |
199.14 Mn |
32.09 Mn |
8.50 Mn |
-8,481.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-8,481.00 |
| Dec 31, 2025 |
87,286.00 |
| Sep 30, 2025 |
-20,603.00 |
| Jun 30, 2025 |
-37,042.00 |
| Mar 31, 2025 |
-46,329.00 |
| Dec 31, 2024 |
-53,299.00 |
| Sep 30, 2024 |
-73,448.00 |
| Jun 30, 2024 |
-35,728.00 |
| Mar 31, 2024 |
-273,549.00 |
| Dec 31, 2023 |
-9,016.00 |
| Sep 30, 2023 |
-7,261.00 |
| Jun 30, 2023 |
-10,697.00 |
| Mar 31, 2023 |
-24,403.00 |
| Dec 31, 2022 |
-14,990.00 |
| Sep 30, 2022 |
-22,352.00 |
| Jun 30, 2022 |
-10,614.00 |
| Mar 31, 2022 |
-8,987.00 |
| Jun 30, 2020 |
409,371.00 |
| Mar 31, 2020 |
4.50 Mn |
| Dec 31, 2019 |
874,015.00 |
